Detalles de la búsqueda
1.
The evolution of ICER's review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER's reports.
J Manag Care Spec Pharm
; 27(11): 1601-1612, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714108
2.
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1686-1696, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143957
3.
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1697, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209749
4.
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
Curr Med Res Opin
; 20(12): 1883-93, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15701206
5.
Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.
Clin Ther
; 36(6): 906-17, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24863260
Resultados
1 -
5
de 5
1
Próxima >
>>